Publication Cover
Immunological Investigations
A Journal of Molecular and Cellular Immunology
Volume 51, 2022 - Issue 4
628
Views
6
CrossRef citations to date
0
Altmetric
Review

Fetomaternal Immune Tolerance: Crucial Mechanisms of Tolerance for Successful Pregnancy in Humans

, ORCID Icon, , , , & show all

References

  • Afshar-Kharghan V. 2017. The role of the complement system in cancer. J Clin Invest. 127(3):780–89.
  • Aluvihare VR, Kallikourdis M, Betz AG. 2004. Regulatory T cells mediate maternal tolerance to the fetus. Nat Immunol. 5(3):266.
  • Anvari F, Dabagh-Gorjani F, SoltaniZangbar M-S, Kamali-Sarvestani E, Malek-Hosseini Z, Gharesi-Fard B. 2015. Investigating the association of IL-17A and IL-17F with susceptibility to pre-eclampsia in Iranian women. Iran J Immunol. 12(2):117–28.
  • Apanius V, Penn D, Slev PR, Ruff LR, Potts WK. 2017. The nature of selection on the major histocompatibility complex. Crit Rev Immunol. 37(2–6):179–224.
  • Azizi R, Soltani-Zangbar MS, Pourmoghadam Z, Mehdizadeh A, Mahdipour M, Sandoghchian S, Danaii S, Koushaein L, Kafil HS,Yousefi M. 2019. Metabolic syndrome mediates inflammatory and oxidative stress responses in patients with recurrent pregnancy loss. J Reprod Immunol. 133:18–26.
  • Baban B, Chandler P, McCool D, Marshall B, Munn DH, Mellor AL. 2004. Indoleamine 2, 3-dioxygenase expression is restricted to fetal trophoblast giant cells during murine gestation and is maternal genome specific. J Reprod Immunol. 61(2):67–77.
  • Barad O, Meiri E, Avniel A, Aharonov R, Barzilai A, Bentwich I, Bentwich I, Einav U, Gilad S, Hurban P, Karov Y, et al. 2004. MicroRNA expression detected by oligonucleotide microarrays: system establishment and expression profiling in human tissues. Genome Res. 14(12):2486–94.
  • Beagley KW, Gockel CM. 2003. Regulation of innate and adaptive immunity by the female sex hormones oestradiol and progesterone. FEMS Immunol Med Microbiol. 38(1):13–22.
  • Bidarimath M, Khalaj K, Wessels JM, Tayade CJC. 2014. MicroRNAs, immune cells and pregnancy. Cell Mol Immunol. 11(6):538.
  • Blank C, Mackensen A. 2007. Contribution of the PD-L1/PD-1 pathway to T-cell exhaustion: an update on implications for chronic infections and tumor evasion. Cancer Immunol Immunoth. 56(5):739–45.
  • Bonney EA, Brown SA. 2014. To drive or be driven: the path of a mouse model of recurrent pregnancy loss. Reproduction. 147(5):R153–R167.
  • Brochez L, Chevolet I, Kruse V. 2017. The rationale of indoleamine 2, 3-dioxygenase inhibition for cancer therapy. Eur J Cancer. 76:167–82.
  • Carosella ED, Rouas-Freiss N, Tronik-Le Roux D, Moreau P, LeMaoult J. 2015. HLA-G: an immune checkpoint molecule. In: Advances in immunology. Vol. 127. USA: Academic Press Inc: Elsevier. p. 33–144.
  • Chaouat G. 2007. The Th1/Th2 paradigm: still important in pregnancy? Paper presented at the Seminars in immunopathology.
  • Chaouat G, Lédée‐Bataille N, Zourbas S, Ostojic S, Dubanchet S, Martal J, Frydman R. 2003. Cytokines, implantation and early abortion: re‐examining the Th1/Th2 paradigm leads to question the single pathway, single therapy concept. Am J Reprod Immunol. 50(3):177–86.
  • Christiansen OB, Kolte AM, Krog MC, Nielsen HS, Egerup P. 2019. Treatment with intravenous immunoglobulin in patients with recurrent pregnancy loss: an update. J Reprod Immunol. 133:37–42.
  • Cobbold SP, Adams E, Graca L, Daley S, Yates S, Paterson A, Robertson, N.J., Nolan, K.F., Fairchild, P.J., Waldmann H. 2006. Immune privilege induced by regulatory T cells in transplantation tolerance. Immunol Rev. 213(1):239–55.
  • Colonna M, Samaridis J, Cella M, Angman L, Allen RL, O’Callaghan CA, Dunbar, R., Ogg, G.S., Cerundolo, V., Rolink A. 1998. Cutting edge: human myelomonocytic cells express an inhibitory receptor for classical and nonclassical MHC class I molecules. J Immunol. 160(7):3096–100.
  • Crispim PCA, Jammal MP, Murta EFC, Nomelini RS. 2020. Endometriosis: what is the influence of immune cells? Immunol Invest. 1–17. doi:https://doi.org/10.1080/08820139.2020.1764577
  • Curiel TJ, Coukos G, Zou L, Alvarez X, Cheng P, Mottram P, Evdemon-Hogan, M., Conejo-Garcia, J.R., Zhang, L., Burow, M., Burow M. 2004. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med. 10(9):942.
  • Dan S, Yichao S. 2014. Immune system modifications and feto-maternal immune tolerance. Chin Med J. 127(17):3171–80.
  • Danaii S, Ghorbani F, Ahmadi M, Abbaszadeh H, Koushaeian L, Soltani-Zangbar MS, Mehdizadeh, A., Hojjat‐Farsangi, M., Kafil, H.S., Aghebati-Maleki, L., Aghebati-Maleki L., et al. 2020. IL-10-producing B cells play important role in the pathogenesis of recurrent pregnancy loss. Int Immunopharmacol. 87:106806.
  • Denny KJ, Woodruff TM, Taylor SM, Callaway LK. 2013. Complement in pregnancy: a delicate balance. Am J Reprod Immunol. 69(1):3–11.
  • Derzsy Z, Prohászka Z, Rigó Jr J, Füst G, Molvarec A. 2010. Activation of the complement system in normal pregnancy and preeclampsia. Mol Immunol. 47(7–8):1500–06.
  • Enninga EAL, Harrington SM, Creedon DJ, Ruano R, Markovic SN, Dong H, Dronca RS. 2018. Immune checkpoint molecules soluble program death ligand 1 and galectin‐9 are increased in pregnancy. Am J Reprod Immunol Microbiol. 79(2):e12795.
  • Estella C, Herrer I, Moreno-Moya JM, Quinonero A, Martinez S, Pellicer A, Simon C. 2012. miRNA signature and Dicer requirement during human endometrial stromal decidualization in vitro. PloS One. 7(7):e41080.
  • Fallarino F, Grohmann U, Hwang KW, Orabona C, Vacca C, Bianchi R, Belladonna, M.L., Fioretti, M.C., Alegre, M.L., Puccetti P. 2003. Modulation of tryptophan catabolism by regulatory T cells. Nat Immunol. 4(12):1206.
  • Falschlehner C, Schaefer U, Walczak H. 2009. Following TRAIL’s path in the immune system. Immunology. 127(2):145–54.
  • Figueiredo AS, Schumacher A. 2016. The T helper type 17/regulatory T cell paradigm in pregnancy. Immunology. 148(1):13–21.
  • Gaynor LM, Colucci F. 2017. Uterine natural killer cells: functional distinctions and influence on pregnancy in humans and mice. Front Immunol. 8:467.
  • Ghaebi M, Nouri M, Ghasemzadeh A, Farzadi L, Jadidi-Niaragh F, Ahmadi M, Yousefi M. 2017. Immune regulatory network in successful pregnancy and reproductive failures. Biomed Pharmacother. 88:61–73.
  • Girardi G. 2008. Complement inhibition keeps mothers calm and avoids fetal rejection. Immunol Invest. 37(5–6):645–59.
  • Goodfellow P, Barnstable C, Bodmer W, Snary D, Crumpton M. 1976. Expression of HLA system antigens on placenta. Transplantation. 22(6):595–603.
  • Gros F, Cabillic F, Toutirais O, Maux AL, Sebti Y, Amiot L. 2008. Soluble HLA‐G molecules impair natural killer/dendritic cell crosstalk via inhibition of dendritic cells. Eur J Immunol. 38(3):742–49.
  • Guleria I, Khosroshahi A, Ansari MJ, Habicht A, Azuma M, Yagita H, Noelle, R.J., Coyle, A., Mellor, A.L., Khoury, S.J., Khoury SJ. 2005. A critical role for the programmed death ligand 1 in fetomaternal tolerance. J Exp Med. 202(2):231–37.
  • Hajipour H, Nejabati HR, Latifi Z, Hamdi K, Bahrami‐asl Z, Fattahi A, Nouri M. 2018. Lymphocytes immunotherapy for preserving pregnancy: mechanisms and challenges. Am J Reprod Immunol. 80(3):e12853.
  • Han C, Wang C, Chen Y, Wang J, Xu X, Hilton T, Cai, W., Zhao, Z., Wu, Y., Li K. 2020. Placenta-derived extracellular vesicles induce preeclampsia in mouse models. Haematologica. 105(6):1686.
  • Heikkinen J, Möttönen M, Alanen A, Lassila O. 2004. Phenotypic characterization of regulatory T cells in the human decidua. Clin Exp Immunol. 136(2):373–78.
  • Hori J, Wang M, Miyashita M, Tanemoto K, Takahashi H, Takemori T, Okumura, K., Yagita, H., Azuma M. 2006. B7-H1-induced apoptosis as a mechanism of immune privilege of corneal allografts. J Immunol. 177(9):5928–35.
  • Hosseini A, Dolati S, Hashemi V, Abdollahpour‐Alitappeh M, Yousefi M. 2018. Regulatory T and T helper 17 cells: their roles in preeclampsia. J Cell Physiol. 233(9):6561–73.
  • Hosseini S, Shokri F, Pour SA, Jeddi-Tehrani M, Nikoo S, Yousefi M, Zarnani A-H. 2016. A shift in the balance of T17 and Treg cells in menstrual blood of women with unexplained recurrent spontaneous abortion. J Reprod Immunol. 116:13–22.
  • Hunt JS. 1989. Cytokine networks in the uteroplacental unit: macrophages as pivotal regulatory cells. J Reprod Immunol. 16(1):1–17.
  • Hunt JS, Langat DL. 2009. HLA-G: a human pregnancy-related immunomodulator. Curr Opin Pharmacol. 9(4):462–69.
  • Hunt JS, Petroff MG, Burnett TG (2000). Uterine leukocytes: key players in pregnancy. Paper presented at the Seminars in cell & developmental biology. 11(2):127–137.
  • Ishii T, Miyazawa M, Takanashi Y, Tanigawa M, Yasuda K, Onouchi H,  Kawabe, N., Mitsushita, J., Hartman, P.S., Ishii N. 2014. Genetically induced oxidative stress in mice causes thrombocytosis, splenomegaly and placental angiodysplasia that leads to recurrent abortion. Redox Biol. 2:679–85.
  • Jiang S, Li C, Olive V, Lykken E, Feng F, Sevilla J, Wan, Y., He, L., Li Q-J. 2011. Molecular dissection of the miR-17-92 cluster’s critical dual roles in promoting Th1 responses and preventing inducible Treg differentiation. Blood J Am Soc Hematol. 118(20):5487–97.
  • Kang S-M, Hofmann A, Le D, Springer ML, Stock PG, Blau HM, Lau, H.T., Stoeckert C. 1997. Immune response and myoblasts that express Fas ligand. Science. 278(5341):1322–24.
  • Kauma SW, Huff TF, Hayes N, Nilkaeo A. 1999. Placental Fas ligand expression is a mechanism for maternal immune tolerance to the fetus. J Clin Endocrinol Metab. 84(6):2188–94.
  • Kudo Y, Boyd C. 2001. The role of l‐tryptophan transport in l‐tryptophan degradation by indoleamine 2, 3‐dioxygenase in human placental explants. J Physiol. 531(2):417–23.
  • Kulshrestha V. 2018. Normal immune function: journey of the fetus. In: Recurrent pregnancy loss. Singapore: Springer; p. 41–50.
  • Kuo C-Y, Baker H, Fries MH, Yoo JJ, Kim PC, Fisher JP. 2017. Bioengineering strategies to treat female infertility. Tissue Eng Part B Rev. 23(3):294–306.
  • Kyurkchiev D, Ivanova-Todorova E, Kyurkchiev SD. 2010. New target cells of the immunomodulatory effects of progesterone. Reprod Biomed Online. 21(3):304–11.
  • Laudanski P, Lemancewicz A, Pierzynski P, Akerlund M, Laudanski T. 2006. Decreased serum level of macrophage inflammatory chemokine-3β/CCL19 in preterm labor and delivery. Eur J Obstetrics Gynecol Reprod Biol. 124(1):23–26.
  • Liang S, Ristich V, Arase H, Dausset J, Carosella ED, Horuzsko A. 2008. Modulation of dendritic cell differentiation by HLA-G and ILT4 requires the IL-6—STAT3 signaling pathway. Proc Nat Acad Sci. 105(24):8357–62.
  • Lovell TM, Woods RJ, Butlin DJ, Brayley KJ, Manyonda IT, Jarvis J, Howell, S, Lowry PJ. 2007. Identification of a novel mammalian post-translational modification, phosphocholine, on placental secretory polypeptides. J Mol Endocrinol. 39(3):189–98.
  • Lubbers R, Van Essen M, Van Kooten C, Trouw L. 2017. Production of complement components by cells of the immune system. Clin Exp Immunol. 188(2):183–94.
  • Mangeney M, Renard M, Schlecht-Louf G, Bouallaga I, Heidmann O, Letzelter C, Richaud, A., Ducos, B., Heidmann T. 2007. Placental syncytins: genetic disjunction between the fusogenic and immunosuppressive activity of retroviral envelope proteins. Proc Nat Acad Sciences. 104(51):20534–39.
  • Mellor AL, Lemos H, Huang L. 2017. indoleamine 2, 3-Dioxygenase and Tolerance: where are we now? Front Immunol. 8:1360.
  • Mincheva‐Nilsson L, Baranov V. 2010. The role of placental exosomes in reproduction. Am J Reprod Immunol Microbiol. 63(6):520–33.
  • Moreno BH, Ribas A. 2015. Anti-programmed cell death protein-1/ligand-1 therapy in different cancers. Br J Cancer. 112(9):1421.
  • Morgan BP, Holmes CH. 2000. Immunology of reproduction: protecting the placenta. Curr Biol. 10(10):R381–R383.
  • Munn DH, Mellor AL. 2013. Indoleamine 2, 3 dioxygenase and metabolic control of immune responses. Trends Immunol. 34(3):137–43.
  • Munn DH, Zhou M, Attwood JT, Bondarev I, Conway SJ, Marshall B, Brown, C., Mellor AL. 1998. Prevention of allogeneic fetal rejection by tryptophan catabolism. Science. 281(5380):1191–93.
  • Murphy SP, Choi JC, Holtz R. 2004. Regulation of major histocompatibility complex class II gene expression in trophoblast cells. Reprod Biol Endocrinol. 2(1):52.
  • Myllynen P, Pasanen M, Pelkonen O. 2005. Human placenta: a human organ for developmental toxicology research and biomonitoring. Placenta. 26(5):361–71.
  • Nabiel Y, ELshahawy H, Mosbah A. 2020. Intrauterine bacterial colonization and endometrial microRNA-17-5p levels in association to endometriosis: a study in an egyptian population. Immunol Invest. 49(6):611–21.
  • Nakagawa K, Kwak‐Kim J, Ota K, Kuroda K, Hisano M, Sugiyama R, Yamaguchi K. 2015. Immunosuppression with tacrolimus improved reproductive outcome of women with repeated implantation failure and elevated peripheral blood TH1/TH2 cell ratios. Am J Reprod Immunol Microbiol. 73(4):353–61.
  • Nishimura H, Honjo T. 2001. PD-1: an inhibitory immunoreceptor involved in peripheral tolerance. Trends Immunol. 22(5):265–68.
  • Ochtrop P. 2017. Selective protein functionalisation via enzymatic phosphocholination. Sweden: Umeå universitet.
  • Orlinick JR, Vaishnaw AK, Elkon KB. 1999. Structure and function of Fas/Fas ligand. Int Rev Immunol. 18(4):293–308.
  • Petroff MG, Chen L, Phillips TA, Azzola D, Sedlmayr P, Hunt JS. 2003. B7 family molecules are favorably positioned at the human maternal-fetal interface. Biol Reprod. 68(5):1496–504.
  • Petroff MG, Kharatyan E, Torry DS, Holets L. 2005. The immunomodulatory proteins B7-DC, B7-H2, and B7-H3 are differentially expressed across gestation in the human placenta. Am J Pathol. 167(2):465–73.
  • Petroff MG, Sedlmayr P, Azzola D, Hunt JS. 2002. Decidual macrophages are potentially susceptible to inhibition by class Ia and class Ib HLA molecules. J Reprod Immunol. 56(1–2):3–17.
  • Piccinni M-P, Lombardelli L, Logiodice F, Kullolli O, Romagnani S, Le Bouteiller P. 2015. T helper cell mediated-tolerance towards fetal allograft in successful pregnancy. Clini Mol Allergy. 13(1):9.
  • Pourmoghadam Z, Soltani-Zangbar MS, Sheikhansari G, Azizi R, Eghbal-Fard S, Mohammadi H, Siahmansouri, H., Aghebati-Maleki, L., Danaii, S., Mehdizadeh A. 2020. Intrauterine administration of autologous hCG-activated peripheral blood mononuclear cells improves pregnancy outcomes in patients with recurrent implantation failure; A double-blind, randomized control trial study. J Reprod Immunol. 142:103182.
  • PrabhuDas M, Bonney E, Caron K, Dey S, Erlebacher A, Fazleabas A, Fisher, S., Golos, T., Matzuk, M., McCune JM. 2015. Immune mechanisms at the maternal-fetal interface: perspectives and challenges. Nat Immunol. 16(4):328.
  • Prokunina L, Castillejo-López C, Öberg F, Gunnarsson I, Berg L, Magnusson V, Brookes, A.J., Tentler, D., Kristjansdóttir, H.,Gröndal G., et al.2002. A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans. Nat Genet. 32(4):666.
  • Qian K, Hu L, Chen H, Li H, Liu N, Li Y, Ai, J., Zhu, G., Tang, Z., Zhang HJE. 2009. Hsa-miR-222 is involved in differentiation of endometrial stromal cells in vitro. Endocrinology. 150(10):4734–43. doi:https://doi.org/10.1210/en.2008-1629.
  • Richardson LS, Kim S, Han A, Menon R. 2020. Modeling ascending infection with a feto-maternal interface organ-on-chip. Lab Chip. 20(23):4486–501.
  • Robertson SA, Sharkey DJ (2001). The role of semen in induction of maternal immune tolerance to pregnancy. Paper presented at the Seminars in immunology. 13(4):243–254.
  • Saito S, Nakashima A, Shima T, Ito M. 2010. Th1/Th2/Th17 and regulatory T‐cell paradigm in pregnancy. Am J Reprod Immunol Microbiol. 63(6):601–10.
  • Saito S, Sasaki Y, Sakai M. 2005. CD4+CD25high regulatory T cells in human pregnancy. J Reprod Immunol. 65(2):111–20.
  • Sakaguchi S. 2004. Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol. 22:531–62.
  • Salmon JE, Heuser C, Triebwasser M, Liszewski MK, Kavanagh D, Roumenina L, Branch, D.W., Goodship, T., Fremeaux-Bacchi, V., Atkinson JP. 2011. Mutations in complement regulatory proteins predispose to preeclampsia: a genetic analysis of the PROMISSE cohort. PLoS Med. 8(3):e1001013.
  • Sasaki Y, Sakai M, Miyazaki S, Higuma S, Shiozaki A, Saito S. 2004. Decidual and peripheral blood CD4+ CD25+ regulatory T cells in early pregnancy subjects and spontaneous abortion cases. MHR: Basic Sci Reprod Med. 10(5):347–53.
  • Schatten H, Constantinescu GM. 2017. Animal models and human reproduction. Hoboken (NJ): John Wiley & Sons.
  • Schjenken JE, Tolosa JM, Paul JW, Clifton VL, Smith R. 2012. Mechanisms of maternal immune tolerance during pregnancy. In: Rijeca C, Zheng J, editors. Recent advances in research on the human placenta. InTech. p. 211–242.
  • Shiina T, Blancher A, Inoko H, Kulski JK. 2017. Comparative genomics of the human, macaque and mouse major histocompatibility complex. Immunology. 150(2):127–38.
  • Shomali N, Hemmatzadeh M, Yousefzadeh Y, Soltani-Zangbar MS, Hamdi K, Mehdizadeh A. 2020. Exosomes: emerging biomarkers and targets in folliculogenesis and endometriosis. J Reprod Immunol. 142:103181.
  • Soliman HH. 2017. Indoleamine 2, 3-dioxygenase. In Marshall JL, editor.  Cancer Therapeutic Targets. New York (NY): Springer. p. 277–284. doi:https://doi.org/10.1007/978-1-4419-0717-2
  • Somerset DA, Zheng Y, Kilby MD, Sansom DM, Drayson MT. 2004. Normal human pregnancy is associated with an elevation in the immune suppressive CD25+ CD4+ regulatory T‐cell subset. Immunology. 112(1):38–43.
  • Sones JL, Davisson RL. 2016. Preeclampsia, of mice and women. Physiol Genomics. 48(8):565–72.
  • Stenqvist A-C, Nagaeva O, Baranov V, Mincheva-Nilsson L. 2013. Exosomes secreted by human placenta carry functional Fas ligand and TRAIL molecules and convey apoptosis in activated immune cells, suggesting exosome-mediated immune privilege of the fetus. J Immunol. 191(11):5515–23.
  • Su L, Liu R, Cheng W, Zhu M, Li X, Zhao S, Yu M. 2014. Expression patterns of microRNAs in porcine endometrium and their potential roles in embryo implantation and placentation. PLoS ONE. 9(2):e87867.
  • Sykes L, MacIntyre DA, Yap XJ, Teoh TG, Bennett PR. 2012. The Th1: th2 dichotomy of pregnancy and preterm labour. Egypt, and Noboru Uchide: Hindawi Publishing Corporation. p. 1–12.
  • Szekeres-Bartho J. 2002. Immunological relationship between the mother and the fetus. Int Rev Immunol. 21(6):471–95.
  • Taglauer ES, Yankee TM, Petroff MG. 2009. Maternal PD-1 regulates accumulation of fetal antigen-specific CD8+ T cells in pregnancy. J Reprod Immunol. 80(1–2):12–21.
  • Talukdar A, Sharma KA, Rai R, Deka D, Rao DN. 2015. Effect of coenzyme Q10 on Th1/Th2 paradigm in females with idiopathic recurrent pregnancy loss. Am J Reprod Immunol Microbiol. 74(2):169–80.
  • Tong M, Chamley L. 2015. Placental extracellular vesicles and feto-maternal communication. In: Cold Spring Harbor perspectives in medicine. United States, and Richard Sever: Cold Spring Harbor Laboratory Press. p. a023028.
  • Tripathi S, Guleria I. 2019. Biomarkers in fetomaternal tolerance. Clin Lab Med. 39(1):145–56.
  • Trowsdale J, Betz AG. 2006. Mother’s little helpers: mechanisms of maternal-fetal tolerance. Nat Immunol. 7(3):241.
  • Wang S, Li M, Sun F, Chen C, Ye J, Li D, Qian, J., Du M. 2021. Th17/Treg‑cell balance in the peripheral blood of pregnant females with a history of recurrent spontaneous abortion receiving progesterone or cyclosporine A . Exp Ther Med. 21(1):1–1.
  • Wang S, Sun M, Yu L, Wang Y, Yao Y, Wang D. 2018. Niacin inhibits apoptosis and rescues premature ovarian failure. Cell Physiol Biochem. 50(6):2060–70.
  • Wang Z, Wang Y, Yang T, Li J, Yang X. 2017. Study of the reparative effects of menstrual-derived stem cells on premature ovarian failure in mice. Stem Cell Res Ther. 8(1):1–14.
  • Xia H-F, Jin X-H, Song -P-P, Cui Y, Liu C-M, Ma XJ. 2009. Temporal and spatial regulation of let-7a in the uterus during embryo implantation in the rat. J Reprod Dev. 56:0910280215–0910280215.
  • Xia H-F, Jin X-H, Song -P-P, Cui Y, Liu C-M, Ma XJI. 2010. Temporal and spatial regulation of miR-320 in the uterus during embryo implantation in the rat. Int J Mol Sci. 11(2):719–30.
  • Xie N, Jia Z, Li L. 2019. miR‑320a upregulation contributes to the development of preeclampsia by inhibiting the growth and invasion of trophoblast cells by targeting interleukin 4. Mol Med Rep. 20(4):3256–64.
  • Xu C, Mao D, Holers VM, Palanca B, Cheng AM, Molina H. 2000. A critical role for murine complement regulator crry in fetomaternal tolerance. Science. 287(5452):498–501.
  • Yan Z, Dai Y, Fu H, Zheng Y, Bao D, Yin Y, Chen, Q., Nie, X., Hao, Q.,Hou D., et al. 2018. Curcumin exerts a protective effect against premature ovarian failure in mice. J Mol Endocrinol. 60(3):261–71.
  • Yi KW, Mamillapalli R, Sahin C, Song J, Tal R, Taylor HS. 2019. Bone marrow-derived cells or CXC motif chemokine 12 (CXCL12) treatment improve thin endometrium in a mouse model. Biol Reprod. 100(1):61–70.
  • Yotsumoto F, Iwaguro H, Harada Y, Sobajima S, Suwabe T, Miyamoto S. 2020. Adipose tissue-derived regenerative cells improve implantation of fertilized eggs in thin endometrium. Regen Med. 15(7):1891–904.
  • Yu L, Zhang Y, Zhao F. 2017. Expression of indoleamine 2, 3-dioxygenase in pregnant mice correlates with CD4+ CD25+ Foxp3+ T regulatory cells. Eur Rev Med Pharmacol Sci. 21(8):1722–28.
  • Yu Y, Wang Y, Feng M. 2008. Human leukocyte antigen–G1 inhibits natural killer cytotoxicity through blocking the activating signal transduction pathway and formation of activating immunologic synapse. Hum Immunol. 69(1):16–23.
  • Zangbar M-S-S, Keshtgar S, Zolghadri J, Gharesi-Fard B. 2016. Antisperm protein targets in azoospermia men. J Hum Reprod Sci. 9(1):47.
  • Zhang YH, Tian M, Tang MX, Liu ZZ, Liao AH. 2015. Recent insight into the role of the PD‐1/PD‐L1 pathway in feto‐maternal tolerance and pregnancy. Am J Reprod Immunol Microbiol. 74(3):201–08.
  • Zhao Y-X, Chen S-R, Su P-P, Huang F-H, Shi Y-C, Shi Q-Y, Lin S. 2019. Using mesenchymal stem cells to treat female infertility: an update on female reproductive diseases. Stem cells international, 2019. Egypt, and Darius Widera: Hindawi Publishing Corporation, p. 1–11.
  • Zhu X-M, Han T, Sargent IL, Yin G-W, Yao Y-Q. 2009. Differential expression profile of microRNAs in human placentas from preeclamptic pregnancies vs normal pregnancies. Am J Obstet Gynecol. 200(6):661. e661-661. e667.
  • Zou Y, Jiang Z, Yu X, Zhang Y, Sun M, Wang W, Ge, Z., De, W., Sun L. 2014. MiR-101 regulates apoptosis of trophoblast HTR-8/SVneo cells by targeting endoplasmic reticulum (ER) protein 44 during preeclampsia. J Hum Hypertens. 28(10):610–16.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.